GMED vs. PEN: Which Stock Is the Better Value Option?
Globus Medical (GMED) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
In recent trading sessions, the US stock market has shown a mixed performance with the Dow Jones Industrial Average extending its winning streak amidst a broader tech sell-off. This backdrop of fluctuating market conditions underscores the importance of considering companies with solid fundamentals and high insider ownership, which can signal confidence in long-term growth prospects from those who know the company best.